BiotechTube
Home/Hansa Biopharma/Hitto Kaufmann
HK

Hitto Kaufmann

Chief Scientific & Technology Officer

Hansa Biopharma

Therapeutic Areas

Autoimmune DiseasesTransplantationGene Therapy

Hansa Biopharma Pipeline

DrugIndicationPhase
ImlifidaseDesensitization in Kidney TransplantationApproved (EU)
HNSA-5487Next-Generation IgG-cleaving EnzymePreclinical/Clinical

Leadership Team at Hansa Biopharma

RA
Renée Aguiar-Lucander
Chief Executive Officer
EB
Evan Ballantyne
Chief Financial Officer
MT
Maria Törnsén
Chief Operating Officer and President U.S.
View full Hansa Biopharma profile